News

A new technology disarms one of the most potent weapons cancer cells use to weaken the effects of chemotherapy drugs.

In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of a common chemotherapy drug, making it dramatically more soluble and effective and less toxic.

New research has uncovered a built-in resistance mechanism to antibody–drug conjugates in some breast cancers and identified a way to overcome this.

Learn how women living in areas with lots of traffic-related air pollution are more likely to develop breast cancer, according to a new analysis of more than 400,000 women.

Researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that contain features of good candidates for a vaccine.

New research identifies why some cancer patients get heart damage during chemotherapy, offering hope for protecting the heart during treatment.

The mirror form of cysteine has been shown to slow the growth of cancer cells, while sparing healthy ones.

Childbearing and breastfeeding reprogram the breast’s immune landscape, offering long-term protection against triple-negative breast cancer.

A Cleveland Clinic study in JAMA found that about 5% of Americans – nearly 17 million people – carry genetic variants linked to higher cancer risk, even without family history. Expanded genetic testing could improve early detection.

An AI system has been designed to aid cancer diagnosis, providing insights into subtyping, biomarker quantification, treatment response assessment and prognostic follow-up.